Can Li

Institution
University of Hong Kong

Country
Hong Kong

Field
Engineering

Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.

(Photo: University of Hong Kong)

AWARDS
  • 2023 Croucher Tak Wah Mak Innovation Award

Related articles

Mucosis Raises US$6.9 Million In Deal With Changchun BCHT

The investment gives Changchun BCHT the license to Mucosis' RSV candidate vaccine and the Mimopath® platform.

InnovFest 2014: Translating Research Into Products

A recent Singapore-based Asian tech rendezvous saw the exchange of ideas the commercialization of university research.

Network Science To Aid Disaster Relief Operations

Scientists from Singapore have modeled the flow of goods and relief efforts to obtain better logistical contingency plans.

One Third Of Malaria Drugs Failed Quality Tests

A systematic review of over 9,000 analyses since 1946 found that 30 percent of the antimalarial drugs from Asia, Africa and South America failed quality tests.

Peking University Collaborates With Canada On Spinal Injury Research

An extension of an earlier agreement in 2011, the new collaboration will focus on applying accredited standards to the rehabilitation of patients with spinal injury.

Research Links Thyroid Disease To Ethnicity

Asians, African Americans and Pacific Islanders have a higher risk of the autoimmune disorder Graves' disease than Caucasians, according to a study.

Two Mouse Models To Study Alzheimer’s Disease

Research in Alzheimer's disease could be accelerated with the use two new mice models that realistically model the disease in humans.

Scientists Discover Role Of APP In The Brain

Usually associated with Alzheimer's disease, scientists have found that the protein APP controls the growth of new brain cells via a target known as microRNA-574-5p.

Vaccine Could Prolong Melanoma Patient Survival

A ten-year study shows that a vaccine called vaccina melanoma cell lysate could help prolong the lives of late stage skin cancer patients.